Molina ($MOH) Medicaid Overbilling and Whistleblower Fraud Case
$MOH investors filed a claim against Molina Healthcare for benefiting from inflated Medicaid billing, ghost visits, and improper kickback arrangements involving third-party clinics.
After a whistleblower lawsuit was unsealed in July 2023, exposing the alleged fraud, $MOH fell 5.3% on July 27, 2023.
$MOH investors can join this case to be notified about potential recovery.
Between January 28, 2021, and July 31, 2023, Molina Healthcare assured investors it was compliant with Medicaid billing rules and had effective oversight of its provider network. The company reported strong financials, attributed growth to its government-backed contracts, and claimed adherence to managed care and regulatory standards.
But behind the scenes, Molina was allegedly engaged in — or knowingly benefited from — a fraudulent billing scheme involving clinics operated by Performance Health (PH), a third-party provider serving low-income Medicaid patients in Texas.
According to a whistleblower complaint unsealed in July 2023, Molina and PH used a network of clinics to:
Inflate reimbursement rates by classifying basic care as higher-cost services,
Bill for non-existent “ghost” doctor visits, and
Use “shared savings” kickback agreements disguised as care coordination fees.
The clinics were allegedly run out of budget hotels and strip malls, with minimal staff, and targeted vulnerable Medicaid populations. Molina continued to receive enhanced capitation payments, even after regulators expressed concern.
In April 2022, Texas Health and Human Services Commission (HHSC) began investigating. By July 2023, Molina was named in federal and state whistleblower complaints, potentially exposing the company to significant financial clawbacks and False Claims Act penalties.
It misrepresented its compliance practices and internal oversight mechanisms.
It failed to disclose the financial risks tied to whistleblower complaints and government inquiries.
Investors argue Molina misled the market about its regulatory compliance and the legitimacy of its Medicaid revenues, resulting in exposure to material legal and financial liabilities.